Astrana Health (NASDAQ:ASTH) Shares Gap Up on Analyst Upgrade

Shares of Astrana Health, Inc. (NASDAQ:ASTH) gapped up before the market opened on Wednesday after Robert W. Baird raised their price target on the stock from $67.00 to $86.00. The stock had previously closed at $42.91, but opened at $44.86. Robert W. Baird currently has an outperform rating on the stock. Astrana Health shares last traded at $44.39, with a volume of 50,865 shares traded.

Several other research analysts also recently weighed in on ASTH. BTIG Research upped their target price on Astrana Health from $60.00 to $70.00 and gave the stock a “buy” rating in a research note on Thursday, October 3rd. KeyCorp started coverage on Astrana Health in a research report on Friday, October 11th. They set a “sector weight” rating for the company. TD Cowen started coverage on Astrana Health in a research report on Monday, October 14th. They set a “buy” rating and a $66.00 price target for the company. Truist Financial boosted their price target on Astrana Health from $50.00 to $59.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Finally, Stifel Nicolaus boosted their price target on Astrana Health from $48.00 to $60.00 and gave the stock a “buy” rating in a research report on Thursday, August 1st. One investment analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Astrana Health presently has an average rating of “Buy” and a consensus target price of $65.17.

Institutional Trading of Astrana Health

Several large investors have recently added to or reduced their stakes in the stock. GAMMA Investing LLC purchased a new stake in Astrana Health in the 3rd quarter valued at $34,000. Nisa Investment Advisors LLC purchased a new stake in Astrana Health in the 3rd quarter valued at $35,000. KBC Group NV purchased a new stake in Astrana Health in the 3rd quarter valued at $70,000. Quest Partners LLC purchased a new position in shares of Astrana Health during the 3rd quarter worth $133,000. Finally, Central Pacific Bank Trust Division purchased a new position in shares of Astrana Health during the 3rd quarter worth $160,000. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Astrana Health Trading Up 3.9 %

The firm has a market capitalization of $2.19 billion, a PE ratio of 33.16, a PEG ratio of 2.09 and a beta of 1.24. The company has a current ratio of 1.91, a quick ratio of 1.84 and a debt-to-equity ratio of 0.60. The business has a fifty day moving average price of $55.40 and a two-hundred day moving average price of $47.72.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.33. The business had revenue of $478.71 million during the quarter, compared to analysts’ expectations of $462.01 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. During the same period in the prior year, the business posted $0.47 EPS. Analysts expect that Astrana Health, Inc. will post 1.12 EPS for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.